Bensalem, PA (PRWEB) April 6, 2011
Xybion Corporation (http://www.xybion.com), a leading provider of preclinical R&D solutions, announced today that WestChina-Frontier PharmaTech Co. (WCFP), the National Chengdu Center for Safety Evaluation of Drugs in Chengdu, China, has licensed Xybion’s Pristima® 6 Preclinical Suite. Pristima® was selected after an exhaustive evaluation of top selling preclinical software systems on the market. Pristima’s unique, end-to-end solution for the management of preclinical data from compound receipt through dossier submission and slide archival stands apart from its competitors and will serve as the foundation for the next stage of WCFP’s rapid expansion.
WCFP is one of the largest preclinical institutions in China and a leading provider of drug development services. To support its expansion efforts, WCFP will leverage Pristima’s full capabilities including Colony Management, General Toxicology, Repro Toxicology, Clinical Pathology and Pathology modules, etc, along with Xybion’s standard validation package and long-term maintenance services.
With a team of 240 individuals, and 2790,000 square feet of modern facilities, WCFP has conducted over 1000 studies in the past five years alone and has formed partnerships with over 50 clients to investigate over 200 compounds including small-molecule, biologic and traditional Chinese medicines. Pristima was carefully selected to provide the automation and scalability to support a fast-growing organization that is dedicated to continuous improvements in productivity and quality while reducing the labor and time to generate the final report for submission.
Dr. Li Wang, CEO of WCFP stated that “there are great expectations for Pristima and for Xybion’s product services staff. We performed a great deal of exercises on Pristima through Xybion’s hosted environment in advance of licensing and found that Pristima was a great match for our needs”. Dr. Wang added “Even through the evaluation and licensing period, we have developed a very comfortable working relationship with Xybion and are excited to deploy Pristima into our working environment as soon as possible”.
With over 3000 licensed users in Preclinical Laboratories in 9 different countries, Pristima is the most modern and flexible enterprise data management system for safety assessment; facilitating the user compliance by supporting the user’s native language for data entry and generating reports in either the native language or in English.
Xybion’s CEO Dr. Pradip Banerjee commented “We are very excited to add WCFP to our growing global family of Pristima clients and we expect to make Pristima the solution-of-choice within the China market and we are doing so by combining the most feature-rich solution with high quality product services on a 24 hour basis.”
About WestChina-Frontier Pharmatech Co. Ltd.
Also known as National Chengdu Center for Safety Evaluation of Drugs, WCFP is a full-service preclinical Contract Research Organization that provides China’s State FDA and the U.S. FDA with GLP-Compliant drug development services. Founded in February of 2000 under the auspices of the Chinese Ministry of Science and Technology, WCFP has been helping its partners worldwide in preclinical research involving drug discovery and safety evaluation.
About Xybion Corporation
Xybion Corporation is a global leader in the development and delivery of enterprise solutions that power innovation and efficiency. We offer a comprehensive portfolio of solutions surrounding Pristima® for Pre-clinical R&D data management and reporting. Pristima software licenses are sold globally as on-premise or as a software-as-a-service leveraging our global data centers. Xybion also features enterprise governance/risk/compliance (eGRC), Enterprise Asset Management, Enterprise Content/Records Management, automated testing and Quality Solutions for clients across multiple industry sectors. Xybion's practical industry solutions are broadly adopted by leading companies across the globe. Xybion compliments its product and services portfolio with a broad range of professional services designed to help organizations achieve higher levels of performance, efficiency, compliance and sustained corporate governance.
# # #